mani
detect
method
use
report
diagnosi
andor
surveil
among
revers
transcript
polymeras
chain
reaction
rtpcr
sensit
claim
detect
copi
virus
howev
report
posit
case
identifi
rtpcr
probabl
due
loss
degrad
viru
rna
sampl
process
even
mutat
viru
genom
therefor
develop
highli
sensit
method
imper
ensur
robust
detect
capabl
goal
improv
sensit
accommod
variou
applic
set
develop
multiplexpcrbas
method
compris
pair
specif
primer
demonstr
effici
detect
low
copi
number
assay
produc
clean
characterist
target
peak
defin
size
allow
direct
identif
posit
electrophoresi
addit
option
sequenc
provid
confirm
well
phylogenet
inform
identifi
viru
es
specif
strain
discrimin
paramount
import
surveil
purpos
repres
global
health
imper
final
also
develop
parallel
multiplexpcrbas
metagenom
method
amen
detect
addit
benefit
potenti
uncov
mutat
divers
novel
pathogen
low
sequenc
depth
sever
epidem
coronaviru
infect
character
pandem
world
health
organ
start
decemb
wuhan
china
quickli
spread
mani
countri
world
caus
death
midmarch
made
daili
impact
variou
aspect
societ
life
around
globe
coronaviru
positivesens
singlestrand
rna
length
genom
current
care
investig
extens
model
accord
chines
nation
center
biolog
inform
new
coronaviru
inform
databas
http
bigdbigaccnncov
note
exhibit
sequenc
similar
among
mani
sequenc
isol
also
highli
similar
coronavirus
present
method
detect
report
discuss
includ
rtpcr
serolog
test
revers
transcriptionloopmedi
isotherm
amplif
current
rtpcr
consid
gold
standard
diagnosi
due
eas
use
high
sensit
rtpcr
report
detect
saliva
pharyng
swab
blood
anal
swab
urin
stool
sputum
specimen
laboratori
condit
rtpcr
methodolog
shown
detect
copi
viru
amplif
target
e
n
viral
gene
confid
interv
howev
posit
case
identifi
rtpcr
rtpcr
neg
result
actual
found
posit
repeat
test
requir
addit
evid
suggest
heat
inactiv
clinic
sampl
caus
loss
viru
particl
therebi
hinder
effici
downstream
diagnosi
therefor
necessari
develop
robust
sensit
specif
highli
quantit
method
deliveri
reliabl
diagnost
assay
urgenc
develop
effect
surveil
method
easili
use
varieti
laboratori
set
underlin
wide
rapid
spread
addit
method
also
distinguish
respiratori
pathogen
influenza
viru
parainfluenza
viru
adenoviru
respiratori
syncyti
viru
rhinoviru
human
metapneumoviru
sar
coronaviru
etc
well
mycoplasma
pneumonia
chlamydia
pneumonia
bacteri
pneumonia
furthermor
provid
nucleotid
sequenc
inform
next
gener
sequenc
ng
prove
essenti
surveil
evolut
inde
phylogenet
studi
genom
sequenc
analysi
provid
better
understand
transmiss
origin
time
rout
guid
policymak
manag
procedur
describ
develop
highli
sensit
robust
detect
assay
incorpor
use
multiplex
pcr
technolog
identifi
theoret
multiplex
pcr
strategi
amplifi
hundr
target
significantli
higher
sensit
rtpcr
may
even
detect
dna
molecul
result
degrad
viru
genom
fragment
multiplex
pcr
shown
effici
lowcost
method
detect
plasmodium
falciparum
infect
high
coverag
median
specif
sensit
moreov
solut
tailor
simultan
address
multipl
question
interest
within
variou
epidemiolog
set
similar
recent
describ
metagenom
approach
identif
also
establish
userfriendli
multiplexpcrbas
metagenom
method
abl
detect
could
also
appli
identif
signific
sequenc
mutat
within
known
virus
uncov
novel
pathogen
limit
sequenc
depth
approxim
million
read
sever
rtpcr
method
detect
report
date
among
two
group
report
detect
copi
viru
investig
opportun
improv
sensit
rtpcr
built
mathemat
model
estim
limit
detect
lod
report
rtpcr
amplicon
length
around
genom
thu
mathemat
model
chose
amplicon
length
genom
size
estim
assumpt
rtpcr
effici
found
rtpcr
assay
could
detect
copi
probabl
fig
consist
experiment
result
obtain
previou
report
model
probabl
rtpcr
assay
detect
one
copi
supplement
fig
find
may
explain
least
part
low
report
detect
rate
posit
sampl
rtpcr
found
lod
appear
independ
viru
genom
size
genom
detect
limit
remain
copi
probabl
one
way
elev
sensit
amplifi
multipl
target
viru
genom
multiplex
pcr
reaction
therebi
increas
frequenc
occurr
mathemat
model
amplifi
multipl
target
advantag
potenti
detect
fragment
degrad
viru
genom
withstand
sequenc
variat
thu
allow
detect
upcom
mutant
amplif
effici
multiplex
pcr
critic
lod
estim
effici
multiplex
pcr
technolog
use
uniqu
molecular
identifi
umi
label
primer
count
amplifi
product
ng
sequenc
supplement
fig
supplement
tabl
howev
amplif
effici
could
lower
amplicon
amplifi
success
templat
use
one
singl
strand
cdna
thu
amplicon
potenti
requir
multiplex
pcr
detect
limit
copi
virus
thu
design
panel
pair
multiplex
pcr
primer
sensit
detect
fig
averag
amplicon
length
amplicon
run
across
entir
genom
gap
amplicon
sinc
observ
effici
multiplex
pcr
amplifi
four
dna
strand
pair
human
chromosom
assum
effici
amplifi
singlestrand
cdna
addit
alreadi
report
variant
recov
directli
amplifi
amplicon
singl
cell
use
technolog
therefor
assum
amplicon
would
amplifi
success
use
mathemat
model
describ
estim
specif
panel
detect
copi
viru
probabl
fig
lod
independ
viru
genom
size
also
design
second
pool
multiplex
pcr
primer
primer
overlap
previou
pool
togeth
two
overlap
pool
primer
deliv
full
coverag
entir
viru
genom
use
pool
detect
calcul
detect
limit
copi
probabl
workflow
design
multiplex
pcr
product
amplifi
secondari
pcr
sampl
index
ng
sequenc
primer
ad
fig
pcr
product
first
analyz
electrophoresi
identifi
potenti
posit
sinc
dozen
amplicon
could
amplifi
singl
copi
electrophoresi
peak
defin
peak
size
expect
multiplex
pcr
amplifi
well
coronavirus
due
high
sequenc
similar
context
electrophoresi
analysi
provid
fast
sensit
indic
infect
famili
virus
addit
gener
librari
allow
investig
ng
sequenc
provid
definit
identif
specif
viru
famili
member
two
plasmid
contain
full
sequenc
n
gene
respect
use
valid
multiplex
pcr
method
amplicon
expect
amplifi
within
panel
simul
use
real
clinic
sampl
two
plasmid
spike
cdna
made
human
total
rna
copi
number
plasmid
determin
dropletbas
digit
pcr
two
plasmid
dilut
approxim
copi
one
copi
amplifi
multiplex
pcr
reaction
librari
peak
expect
size
obtain
copi
plasmid
fig
quantif
peak
demonstr
wide
dynam
rang
copi
plasmid
fig
yield
librari
start
satur
copi
number
possibl
satur
point
could
even
lower
amplicon
amplifi
posit
clinic
sampl
librari
peak
could
observ
even
fewer
copi
viru
contrast
detect
quantiti
singl
target
n
gene
rtpcr
rapidli
drop
use
copi
fig
supplement
fig
estim
aforement
mathemat
model
amplicon
chanc
detect
one
singl
copi
test
hypothesi
amplifi
one
copi
plasmid
multiplex
pcr
reaction
theoret
calcul
give
probabl
sampl
copi
chanc
detect
base
multiplex
pcr
effici
realiti
experiment
observ
significantli
higher
probabl
detect
copi
fig
result
suggest
effici
multiplex
pcr
actual
higher
previous
estim
singlestrand
cdna
amplifi
amplifi
product
sequenc
found
recov
read
within
rang
rel
depth
plasmid
uniformli
distribut
across
gc
rang
fig
detect
copi
plasmid
read
one
amplicon
lower
averag
approxim
amplicon
recov
copi
plasmid
copi
copi
fig
two
plasmid
contain
n
gene
respect
dilut
human
cdna
amplifi
multiplex
pcr
pool
pair
primer
number
plasmid
copi
per
reaction
determin
ddpcr
result
product
obtain
multiplex
pcr
resolv
electrophoresi
specif
amplif
product
librari
still
seen
copi
plasmid
b
librari
yield
detect
copi
plasmid
multiplex
pcr
black
line
copi
still
detect
rtpcr
differ
red
order
discov
highli
mutat
virus
unknown
pathogen
subsequ
develop
userfriendli
multiplexpcrbas
metagenom
method
method
random
hexameradapt
use
amplifi
dna
cdna
target
multiplex
pcr
reaction
larg
amount
nonspecif
amplif
product
remov
use
paragon
genom
proprietari
background
remov
reagent
thu
resolv
librari
suitabl
sequenc
rna
sampl
revers
transcript
reagent
addit
use
convert
rna
cdna
result
significantli
reduc
amount
human
ribosom
rna
speci
sequenc
librari
made
copi
n
genecontain
plasmid
spike
ng
human
gdna
roughli
repres
haploid
genom
even
though
molar
ratio
viral
target
human
haploid
genom
compar
n
gene
encompass
target
neglig
fraction
billion
base
pair
human
genom
everi
region
human
genom
amplifi
sequenc
million
read
per
sampl
one
read
viral
target
would
recov
fact
result
show
recov
base
recov
read
within
viral
n
gene
fig
supplement
tabl
mitochondri
target
cover
respect
fig
base
coverag
significantli
higher
human
target
fig
contrast
region
human
chromosom
amplifi
furthermor
human
exon
region
preferenti
amplifi
fig
suggest
random
hexam
deselect
larg
portion
human
genom
favor
amplifi
region
random
base
composit
inde
long
gap
absenc
coverag
larg
repetit
region
observ
human
chromosom
fig
contrari
gap
mitochondri
region
significantli
shorter
fig
wherea
amplifi
target
overlap
longer
human
target
fig
coverag
n
gene
mitochondri
chromosom
fig
coverag
roughli
within
rang
observ
human
chromosom
fig
therefor
increas
sequenc
depth
might
significantli
improv
coverag
differ
coverag
routin
observ
multiplex
pcr
technolog
supplement
tabl
supplement
fig
abl
detect
region
n
gene
librari
gener
use
copi
plasmid
averag
base
coverag
total
sequenc
depth
million
read
target
bp
length
n
gene
preferenti
amplifi
even
copi
number
went
copi
target
still
detect
repres
target
region
copi
plasmid
amplifi
respect
random
hexameradapt
use
multiplex
pcr
amplifi
copi
plasmid
background
haploid
human
gdna
molecul
result
librari
sequenc
averag
million
total
read
total
base
recov
n
gene
b
n
gene
human
mitochondri
chromosom
amplifi
coverag
human
chromosom
c
averag
n
gene
cover
mitochondria
human
chromosom
human
exon
rel
overamplifi
higher
compar
actual
ratio
within
genom
e
gap
long
region
absenc
amplif
observ
human
chromosom
exampl
shown
chromosom
small
gap
addit
found
enlarg
cluster
amplif
long
absent
region
red
doubl
arrow
overlap
repetit
region
chromosom
f
represent
recov
region
n
gene
human
mitochondri
chromosom
coverag
n
gene
mitochondri
chromosom
g
length
major
chromosom
amplif
product
cluster
around
amplifi
region
n
gene
well
mitochondri
chromosom
significantli
longer
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
even
low
number
plasmid
use
copi
sever
target
bp
n
gene
still
detect
total
sequenc
depth
million
read
target
repres
n
gene
copi
plasmid
use
respect
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
tremend
effort
made
around
world
provid
fast
reliabl
diagnost
method
rtpcr
current
preferenti
frequent
use
detect
strategi
yet
found
lod
rtpcr
sit
around
copi
confid
independ
size
target
genom
consequ
overcom
instabl
rna
genom
sequenc
variabl
viru
genom
due
evolut
sensit
robust
method
requir
report
develop
multiplex
pcr
assay
highsensit
identif
infect
pair
primer
method
enabl
detect
low
copi
number
potenti
degrad
fragment
viral
genom
even
mutat
variant
high
confid
pair
primer
cover
genom
detect
limit
copi
viru
fewer
target
success
amplifi
case
one
copi
viru
estim
viral
genom
sequenc
could
amplifi
suffici
produc
conspicu
peak
electrophoresi
initi
indic
posit
use
ng
sequenc
provid
nucleic
acidlevel
inform
confirm
identif
provid
addit
evid
phylogenet
analysi
addit
method
robust
accur
easili
perform
differ
level
expertis
variou
laboratori
set
furthermor
also
propos
metagenom
method
potenti
identif
unknown
pathogen
metagenom
technolog
usual
requir
million
sequenc
read
order
detect
minuscul
number
target
embed
massiv
amount
human
background
howev
method
appear
select
amplifi
target
sequenc
bia
permit
obtent
around
target
base
sequenc
depth
million
total
read
thu
especi
suitabl
detect
novel
pathogen
highli
genet
unstabl
pathogen
influenza
virus
exact
mechan
deselect
human
sequenc
current
investig
random
hexam
prefer
chromosom
structur
sequenc
composit
target
length
circular
methyl
statu
telomer
centromer
region
well
edg
effect
may
influenc
outcom
ultim
observ
preferenti
amplif
toward
random
sequenc
could
provid
us
advantag
edg
continu
improv
method
univers
human
refer
rna
agil
technolog
inc
cat
plasmid
contain
either
n
gene
puc
pucn
respect
purchas
sangon
biotech
shanghai
china
pcr
primer
use
ddpcr
rtpcr
reaction
gene
n
gene
respect
pair
multiplex
pcr
primer
cover
entir
genom
panel
design
paragon
genom
inc
separ
two
pool
pool
contain
pair
primer
use
detect
multiplex
pcr
univers
human
refer
rna
convert
cdna
use
random
primer
iv
revers
transcriptas
follow
supplier
recommend
method
thermo
fisher
scientif
cat
revers
transcript
cdna
purifi
volum
magnet
bead
wash
twice
ethanol
final
purifi
cdna
dissolv
te
buffer
use
per
multiplex
pcr
reaction
panel
design
base
sequenc
http
total
primer
pair
distribut
two
pool
select
proprietari
panel
design
pipelin
cover
whole
genom
except
base
end
primer
optim
preferenti
amplifi
cdna
versu
background
human
cdna
genom
dna
also
optim
uniformli
amplifi
cover
genom
plasmid
puc
pucn
combin
human
cdna
use
multiplex
pcr
reaction
paragon
genom
multiplex
pcr
reagent
protocol
use
briefli
multiplex
pcr
reaction
made
combin
mpcr
mix
pool
panel
plasmid
puc
pucn
cdna
reaction
run
thermal
cycler
cycl
termin
addit
stop
buffer
reaction
purifi
magnet
bead
follow
secondari
pcr
pair
primer
cycl
secondari
pcr
ad
sampl
index
sequenc
adapt
allow
sequenc
result
product
high
throughput
sequenc
final
bead
purif
perform
secondari
pcr
follow
librari
interrog
use
bioanalyz
instrument
agil
high
sensit
dna
kit
agil
technolog
inc
part
copyright
holder
preprint
peerreview
